China Biologic Products, Inc. (CBPO) Reports Q3 EPS of $0.54, Updated Outlook

Article Related Press Releases (1) Stock Quotes (1) Comments (0)

China Biologic Products, Inc. (NASDAQ: CBPO) reported Q3 EPS of $0.54, versus $0.42 reported last year. Revenue for the quarter came in at $53.1 million, versus $41.3 million reported last year.

Outlook

For the full year of 2012, the Company now expects sales to reach or surpass the high end of previous guidance of $176 million, representing mid-to-high-teens annual growth. The Company estimates full year non-GAAP adjusted net income to be in the range of $46 million to $48 million, compared to the previous guidance range of $38 million to $40 million.

For earnings history and earnings-related data on China Biologic Products, Inc. (CBPO) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
• Booz Allen Hamilton (BAH) Tops Q4 EPS by 3c; Guides In-Line FY14 EPS
• Lowes Cos. (LOW) Misses Q1 EPS by 2c; Reaffirms FY13 Outlook

Create E-mail Alert Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?